CH417605A - Procédé de préparation de dérivés de la 8-benzylxanthine - Google Patents

Procédé de préparation de dérivés de la 8-benzylxanthine

Info

Publication number
CH417605A
CH417605A CH471761A CH471761A CH417605A CH 417605 A CH417605 A CH 417605A CH 471761 A CH471761 A CH 471761A CH 471761 A CH471761 A CH 471761A CH 417605 A CH417605 A CH 417605A
Authority
CH
Switzerland
Prior art keywords
benzylxanthine
derivatives
preparation
benzylxanthine derivatives
Prior art date
Application number
CH471761A
Other languages
English (en)
French (fr)
Inventor
Rachel De Ridder Rene
Original Assignee
Manuf Prod Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manuf Prod Pharma filed Critical Manuf Prod Pharma
Publication of CH417605A publication Critical patent/CH417605A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH471761A 1960-04-22 1961-04-21 Procédé de préparation de dérivés de la 8-benzylxanthine CH417605A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB14251/60A GB947494A (en) 1960-04-22 1960-04-22 New dialkyl xanthine derivatives and a process for the preparation thereof

Publications (1)

Publication Number Publication Date
CH417605A true CH417605A (fr) 1966-07-31

Family

ID=10037767

Family Applications (1)

Application Number Title Priority Date Filing Date
CH471761A CH417605A (fr) 1960-04-22 1961-04-21 Procédé de préparation de dérivés de la 8-benzylxanthine

Country Status (5)

Country Link
BE (1) BE602887A (xx)
CH (1) CH417605A (xx)
ES (1) ES266787A1 (xx)
GB (1) GB947494A (xx)
LU (1) LU40044A1 (xx)

Also Published As

Publication number Publication date
GB947494A (en) 1964-01-22
LU40044A1 (xx) 1961-10-20
BE602887A (fr) 1961-10-23
ES266787A1 (es) 1961-12-01

Similar Documents

Publication Publication Date Title
CH434250A (fr) Procédé de préparation de nouveaux dérivés estradiéniques
CH406224A (fr) Procédé de préparation de dérivés trialcoxylés de la benzyl-1-pipérazine
CH401070A (fr) Procédé de préparation de dérivés de 8-benzyl-1.3-dialcoyl-xanthines
BE607191A (fr) Procédé de préparation de dérivés de sucres
FR1309818A (fr) Procédé de préparation de dérivés de 20-alcoyl-amino-stéroïdes
CH419128A (fr) Procédé de préparation de dérivés de la pyrrolidine
FR1320300A (fr) Procédé de préparation de dérivés de la 3-phényl-7-hydroxy-chromone
CH404658A (fr) Procédé de préparation de dérivés du bis-hydroxy-méthylènepregnane
FR1444661A (fr) Procédé de préparation de dérivés de p-alkyl-benzyl-tropinium
CH398614A (fr) Procédé de préparation de nouveaux dérivés de la pipérazine
CH411841A (fr) Procédé de préparation de dérivés insaturés de la trihydroxy-acétophénone
BE602514A (fr) Procédé de préparation de dérivés de la phénothiazine
BE604521A (fr) Procédé de préparation de dérivés de la 4-aminoantipyrine
FR1343475A (fr) Procédé de préparation de dérivés de 1, 4-benzodiazéipne
FR1256375A (fr) Procédé de préparation de dérivés de la nitro-acétophénone
CH417605A (fr) Procédé de préparation de dérivés de la 8-benzylxanthine
FR1276852A (fr) Procédé de préparation de dérivés du nu-aralkyl-nor-tropane-3-alpha ou 3-beta-ol
CH395079A (fr) Procédé de préparation de dérivés du bis-hydroxyméthylène-prégnane
CH398563A (fr) Procédé de préparation de dérivés du cyclopentanonaphtalène
CH394192A (fr) Procédé de préparation de dérivés du bis- hydroxyméthylène-prégnane
CH411861A (fr) Procédé de préparation de dérivés du bis-hydroxyméthylène-prégnane
CH414611A (fr) Procédé de préparation de dérivés du bis-hydroxyméthylène-prégnane
FR1289014A (fr) Procédé de préparation de dérivés de la phénothiazine
FR1252387A (fr) Procédé de préparation de dérivés de 2, 3-dimercaptoquinoxaline
MC302A1 (fr) Procédé de préparation de nouveaux dérivés de N-pyridylmethyl-benzamide